Literature DB >> 20471324

Idiopathic generalized epilepsy with generalized tonic-clonic seizures (IGE-GTC): a population-based cohort with >20 year follow up for medical and social outcome.

Peter Camfield1, Carol Camfield.   

Abstract

Children with idiopathic generalized epilepsy with only generalized tonic-clonic seizures (IGE-GTC) were selected from the Nova Scotia Childhood Epilepsy population-based cohort. All were neurologically and intellectually normal with generalized spike-wave on EEG. Of the epilepsy cohort of 692, 40(5.8%) had IGE-GTC. Follow-up averaged 22.2+/-7.6 years. Twenty-seven (75%) had a complete terminal remission (seizure-free, off medication) for 16.1+/-8.6 years. There were no deaths or intractable seizures. For those >21 years of age at follow up (N=30), major adverse social outcomes were psychiatric diagnosis 8 (27%), no high school graduation 12 (40%), pregnancy outside a stable relationship 11 (38%), living alone 7 (23%), unemployment 10 (33%) and criminal conviction 2 (7%). Satisfaction with their lives, friendships and social activities were reported by 55-65%. IGE-GTC is a recognizable, relatively benign epilepsy syndrome with complete remission in 75%. Learning problems and unsatisfactory social outcome are unfortunately common. Copyright (c) 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20471324     DOI: 10.1016/j.yebeh.2010.02.014

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  15 in total

1.  Seizure and Psychosocial Outcomes of Childhood and Juvenile Onset Generalized Epilepsies: Wolf in Sheep's Clothing, or Well-Dressed Wolf?

Authors:  Katherine Nickels
Journal:  Epilepsy Curr       Date:  2015 May-Jun       Impact factor: 7.500

2.  Determinants of Social Outcomes in Adults With Childhood-onset Epilepsy.

Authors:  Anne T Berg; Christine B Baca; Karen Rychlik; Barbara G Vickrey; Rochelle Caplan; Francine M Testa; Susan R Levy
Journal:  Pediatrics       Date:  2016-03-16       Impact factor: 7.124

3.  Complete remission of childhood-onset epilepsy: stability and prediction over two decades.

Authors:  Anne T Berg; Karen Rychlik; Susan R Levy; Francine M Testa
Journal:  Brain       Date:  2014-10-22       Impact factor: 13.501

4.  Pediatric epilepsy: Five new things.

Authors:  Kelly Knupp; Susan Koh; Kristen Park
Journal:  Neurol Clin Pract       Date:  2012-03

5.  Social outcomes of young adults with childhood-onset epilepsy: A case-sibling-control study.

Authors:  Christine B Baca; Frances Barry; Barbara G Vickrey; Rochelle Caplan; Anne T Berg
Journal:  Epilepsia       Date:  2017-04-04       Impact factor: 5.864

Review 6.  A Systematic Review of Psychiatric and Psychosocial Comorbidities of Genetic Generalised Epilepsies (GGE).

Authors:  A Loughman; N A Bendrups; W J D'Souza
Journal:  Neuropsychol Rev       Date:  2016-10-10       Impact factor: 7.444

Review 7.  Genetic generalized epilepsies in adults - challenging assumptions and dogmas.

Authors:  Bernd J Vorderwülbecke; Britta Wandschneider; Yvonne Weber; Martin Holtkamp
Journal:  Nat Rev Neurol       Date:  2021-11-26       Impact factor: 42.937

8.  Transition from pediatric to adult epilepsy care: a difficult process marked by medical and social crisis.

Authors:  Peter Camfield; Carol Camfield; Bernd Pohlmann-Eden
Journal:  Epilepsy Curr       Date:  2012-07       Impact factor: 7.500

9.  Factor structure of the Child Health Questionnaire Parent Form-50 and predictors of health-related quality of life in children with epilepsy.

Authors:  Mark A Ferro; Jeanne M Landgraf; Kathy N Speechley
Journal:  Qual Life Res       Date:  2013-01-20       Impact factor: 4.147

10.  Recurrence rates and risk factors for seizure recurrence following antiseizure medication withdrawal in adolescent patients with genetic generalized epilepsy.

Authors:  Takao Komatsubara; Yu Kobayashi; Akiko Hiraiwa; Shinichi Magara; Moemi Hojo; Takeshi Ono; Kenichi Okazaki; Masafumi Fukuda; Jun Tohyama
Journal:  Epilepsia Open       Date:  2022-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.